Humatrope and neoplasm progression Patient Reports February 12, 2012
Humatrope Side Effects Report #4589391-9
Humatrope side effect was reported by a Physician from on Jan 28, 2005. Male patient, 33 years of age, was diagnosed with pituitary tumour benign and was treated with Humatrope. After drug was administered, patient experienced the following side effects: neoplasm progression, pituitary tumour. Humatrope dosage: 0.4 MG/DAY DAY. Patient recovered.
Humatrope Side Effects Report #5108912-0
Humatrope side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 31, 2006. Male patient was diagnosed with libido decreased and was treated with Humatrope. After drug was administered, patient experienced the following side effects: asthenia, fatigue, neoplasm progression, procedural complication. Humatrope dosage: 3 CLICKS OF A 6MG CARTRIDGE. During the same period patient was treated with HUMATROPEN. Patient recovered.
Humatrope Side Effects Report #4870288-1
Humatrope side effect was reported by a Physician from UNITED KINGDOM on Dec 07, 2005. Female patient, 75 years of age, was diagnosed with growth hormone deficiency and was treated with Humatrope. After drug was administered, patient experienced the following side effects: neoplasm progression, visual disturbance. Humatrope dosage: unknown. Patient recovered.
Humatrope Side Effects Report #5729449-1
Humatrope side effect was reported by a Physician from UNITED KINGDOM on Apr 24, 2008. Male patient, 54 years of age, was diagnosed with growth hormone deficiency and was treated with Humatrope. After drug was administered, patient experienced the following side effects: neoplasm progression. Humatrope dosage: unknown. Patient died.
Humatrope Side Effects Report #4870287-X
Humatrope side effect was reported by a Physician from UNITED KINGDOM on Dec 07, 2005. Male patient, 54 years of age, was diagnosed with growth hormone deficiency and was treated with Humatrope. After drug was administered, patient experienced the following side effects: neoplasm progression, neoplasm recurrence. Humatrope dosage: unknown. Patient recovered.
Humatrope Side Effects Report #4607215-8
Humatrope side effect was reported by a Consumer or non-health professional from on Feb 18, 2005. Female patient, 50 years of age, weighting 167.6 lb, was diagnosed with growth hormone deficiency and was treated with Humatrope. After drug was administered, patient experienced the following side effects: condition aggravated, headache
, hemianopia, neoplasm progression, optic atrophy, visual pathway disorder. Humatrope dosage: 0.4 MG/1 DAY. During the same period patient was treated with SYNTHROID, ESTRADERM. Patient was hospitalized. Patient recovered.Humatrope Side Effects Report #4673862-0
Humatrope side effect was reported by a Consumer or non-health professional from on May 13, 2005. Female patient, 48 years of age, weighting 141.1 lb, was diagnosed with growth hormone deficiency and was treated with Humatrope. After drug was administered, patient experienced the following side effects: eye movement disorder, hemiparesis, metastases to central nervous system, neoplasm progression, pituitary tumour recurrent. Humatrope dosage: unknown. During the same period patient was treated with ASTRIX, METOPROLOL TARTRATE, AMLODIPINE. Patient was hospitalized. Patient recovered.
Humatrope Side Effects Report #4784426-2
Humatrope side effect was reported by a Physician from UNITED STATES on Sept 14, 2005. Female patient, 41 years of age, weighting 172.0 lb, was diagnosed with growth hormone deficiency and was treated with Humatrope. After drug was administered, patient experienced the following side effects: areflexia, blood pressure systolic increased, feeling abnormal, meningioma, neoplasm progression, optic atrophy. Humatrope dosage: 0.2 MG/1 DAY. During the same period patient was treated with SYNTHROID, CORTEF, VITMAIN, DDAVP, OMEPRAZOLE, CLARITIN, ST JOHN, GINKGO BILOBA. Patient was hospitalized. Patient recovered.
Humatrope Side Effects Report #4870284-4
Humatrope side effect was reported by a Physician from UNITED KINGDOM on Dec 07, 2005. Female patient, 30 years of age, was diagnosed with growth hormone deficiency and was treated with Humatrope. After drug was administered, patient experienced the following side effects: craniopharyngioma, neoplasm progression. Humatrope dosage: unknown. Patient recovered.
Humatrope Side Effects Report #5979473-9
Humatrope side effect was reported by a Physician from JAPAN on Nov 27, 2008. Female patient, 15 years of age, was diagnosed with growth hormone deficiency and was treated with Humatrope. After drug was administered, patient experienced the following side effects: neoplasm progression. Humatrope dosage: unknown. Patient recovered.
Humatrope Side Effects Report #4869968-3
Humatrope side effect was reported by a Health Professional from UNITED STATES on Dec 06, 2005. Female patient, 41 years of age, weighting 171.1 lb, was diagnosed with blood growth hormone decreased and was treated with Humatrope. After drug was administered, patient experienced the following side effects: blood pressure systolic increased, meningioma, neoplasm progression, paraesthesia, therapeutic response decreased. Humatrope dosage: 0.2 MG, DAILY (1/D), SUBCUTANEOUS. During the same period patient was treated with SYNTHROID, CORTEF, DDAVP, OMEPRAZOLE, CLARITIN, ST JOHN, GINKO BILOBA. Patient was hospitalized. Patient recovered.
Humatrope Side Effects Report #4986598-3
Humatrope side effect was reported by a Physician from CANADA on Apr 05, 2006. Female patient was treated with Humatrope. After drug was administered, patient experienced the following side effects: neoplasm progression. Humatrope dosage: 0.3 MG, DAILY (1/D), SUBCUTANEOUS. During the same period patient was treated with CORTISONE ACETATE, THYROXINE. Patient recovered.
Humatrope and neoplasm progression 